Urinary autotaxin concentrations are associated with kidney injury.

Clin Chim Acta

Department of Clinical Laboratory, the University of Tokyo Hospital, Tokyo, Japan; Department of Clinical Laboratory Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.

Published: October 2020

Background: While basic researches have shown the involvement of the autotaxin-lysophosphatidic acid (ATX-LPA) axis in the pathogenesis of kidney diseases, no clinical studies have revealed the association between urinary ATX concentrations and kidney disease yet. We investigate the clinical characteristics in relation to the urinary ATX concentrations and the potential association between urinary ATX concentrations and various kidney diseases.

Methods: We measured the urinary ATX concentrations in residual urine samples after routine clinical testing from a total of 326 subjects with various kidney diseases and healthy subjects. We compared the urinary ATX concentrations in relation to clinical parameters and urinary biomarkers, and investigated their association with various kidney diseases.

Results: The urinary ATX concentrations were associated with the gender, eGFR, presence/absence of hematuria, serum ATX, urinary concentrations of total protein (TP), microalbumin, N-acetyl-β-D-glucosaminidase (NAG), α1-microglobulin (α1-MG), and transforming growth factor-β. Multiple regression analyses identified urinary α1-MG, age, urinary TP, NAG, and hematuria as being significantly associated with the urinary ATX concentrations. Urinary ATX concentrations were higher in subjects with membranous nephropathy and systemic lupus erythematosus than in the control subjects.

Conclusions: Urinary ATX might be associated with pathological conditions of the kidney associated with kidney injury.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2020.06.019DOI Listing

Publication Analysis

Top Keywords

urinary atx
36
atx concentrations
32
urinary
14
concentrations
10
atx
10
concentrations associated
8
kidney
8
associated kidney
8
kidney injury
8
kidney diseases
8

Similar Publications

Astaxanthin (ATX) is a strong antioxidant drug. This study aimed to investigate the effects of ATX on podocytes in diabetic nephropathy and the underlying renal protective mechanism of ATX, which leads to pathological crosstalk with mesangial cells. In this study, diabetic rats treated with ATX exhibited reduced 24-h urinary protein excretion and decreased blood glucose and lipid levels compared to vehicle-treated rats.

View Article and Find Full Text PDF

Protective effect of astaxanthin on ANCA-associated vasculitis.

Int Immunopharmacol

May 2024

Department of Renal Division, Affiliated Hospital of Qingdao University, Qingdao 266555, China. Electronic address:

Objective: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease characterized by inflammation and fibrinoid necrosis of medium and small vessels, and its pathogenesis is closely related to inflammation and oxidative stress. Astaxanthin (ATX) is a carotenoid with anti-inflammatory, antioxidant, and immunomodulatory effects. We hypothesized that ATX could play a role in AAV treatment.

View Article and Find Full Text PDF

Effect of BBT-877, a novel inhibitor of ATX, on a mouse model of type 1 diabetic nephropathy.

Aging (Albany NY)

August 2022

College of Pharmacy and Gachon Institute of Pharmaceutical Science, Gachon University, Incheon, Korea.

Article Synopsis
  • Diabetic nephropathy (DN) is a serious complication of diabetes influenced by autotaxin (ATX), an enzyme linked to kidney issues through its production of lysophosphatidic acid (LPA).* -
  • This study explored the effects of BBT-877, an ATX inhibitor, on DN in mice with diabetes, finding that it significantly improved kidney function markers and decreased levels of inflammation and fibrosis.* -
  • The findings suggest that targeting ATX with BBT-877 may offer a promising therapeutic approach for preventing the progression of diabetic nephropathy.*
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers used a specific model with Sprague Dawley rats as kidney donors and Wistar rats as recipients, measuring IL-17 levels at various days post-surgery through specialized techniques.
  • * Results showed that IL-17 levels significantly increased in transplant recipients experiencing acute rejection, and using the immunosuppressant cyclosporin A helped prevent this increase.
View Article and Find Full Text PDF

Renal Artery Repair with Kidney Autotransplantation for Renal Artery Aneurysms.

Eur J Vasc Endovasc Surg

May 2022

Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany. Electronic address:

Objective: Kidney autotransplantation (ATx) is a treatment option for distal renal artery aneurysm (RAA). This systematic review evaluated the indications, treatment strategy, and outcome of kidney ATx to verify the value of this procedure in treating RAA.

Data Sources: PubMed, Embase, and Web of Science.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!